<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="by which naringenin exhibits its diverse bioactivities is through the" exact="suppression" post="of oxidative stress, which is caused by various free"/>
 <result pre="al. in Uruguay has reported an approximately 70% decrease in" exact="cancer" post="risk associated with the esophagus, larynx, oral cavity, and"/>
 <result pre="By inhibition of CYP19, it helps to control breast and" exact="prostate cancer." post="It has anti-proliferative properties exhibited by downregulation of ROS"/>
 <result pre="causes cell cycle arrest in G and S phases in" exact="cancer" post="cells by inhibiting cyclin, and CDK helps to control"/>
 <result pre="induction of ERÎ±-dependent p38 kinase activation causes pro-apoptotic activities in" exact="cancer" post="cells. Naringenin exhibits its angio-inhibitory effect by decreasing vascular"/>
 <result pre="be of significant anti-prostate- and anti-breast-cancer potential [37]. In estrogen-dependent" exact="breast cancer," post="naringenin has exhibited inhibitory effects on estrogen synthetase enzyme"/>
 <result pre="serve as specific targets for naringenin to prevent or stop" exact="cancer" post="development. Investigations have revealed that the generation of ROS"/>
 <result pre="of the key mechanisms responsible for promoting different stages of" exact="cancer" post="[41]. Naringenin, as an antioxidant, does efficiently counter such"/>
 <result pre="demonstrated in numerous in vitro studies using various kinds of" exact="cancer" post="cells [43,44]. Naringenin inhibits xanthine oxidase [45] cyclooxygenase, lipoxygenase"/>
 <result pre="and hampers the proliferation of tumor cells. In experimentally induced" exact="colon cancer," post="naringenin has been reported to inhibit hyperproliferation. Inhibition of"/>
 <result pre="been found to suppress the rate of PCNA expression in" exact="leukemia" post="cell line HL-60, thereby indicating its anti-proliferative activity [55]."/>
 <result pre="been also shown to arrest the growth in K562 human" exact="leukemia" post="cell line, particularly in the G0/G1 phase of the"/>
 <result pre="[57]. Naringenin is believed to inhibit unregulated growth in different" exact="cancer" post="cell types executing apoptosis, such as in K562 cell"/>
 <result pre="in pancreatic cells [67]. 3.2. Anti-Diabetic Activity Diabetes is a" exact="metabolic disorder" post="of endocrine origin identified by elevated blood glucose levels."/>
 <result pre="adipocytes. Further pathology behind the advancement of insulin resistance and" exact="diabetes mellitus" post="is the interaction of adipocytes and macrophages in the"/>
 <result pre="the inflammation of adipose tissue. Naringenin counteracts this inflammation by" exact="suppression" post="of monocyte chemoattractant protein-1 (MCP-1) and migration of macrophages"/>
 <result pre="biomolecules, lipids have an inevitable role in the pathogenesis of" exact="diabetes mellitus" post="[80]. A common metabolic anomaly related to diabetes mellitus"/>
 <result pre="of diabetes mellitus [80]. A common metabolic anomaly related to" exact="diabetes mellitus" post="is dyslipidemia. Research findings have reported various abnormalities in"/>
 <result pre="abnormalities in lipid metabolism attended by the risk of cardiovascular" exact="arteriosclerosis" post="in DM patients [81]. Naringenin has been reported to"/>
 <result pre="neuropathic pain is one of the chief complications associated with" exact="diabetes mellitus" post="[83]. Afflicted individuals often have complaints of â€œshock-like ambiancesâ€�"/>
 <result pre="Wistar rats have shown reduced pain and allodynic effects of" exact="diabetic neuropathy" post="induced by streptozotocin [86]. Naringenin has also exhibited analgesic"/>
 <result pre="rats have shown reduced pain and allodynic effects of diabetic" exact="neuropathy" post="induced by streptozotocin [86]. Naringenin has also exhibited analgesic"/>
 <result pre="triggers severe liver damage and intensifies the probability of chronic" exact="liver disease" post="[91,92]. Production of reactive oxygen species (ROS) may be"/>
 <result pre="Additionally, naringenin has been shown to alleviate inflammation induced by" exact="hyperglycemia" post="in streptozotocin-nicotinamide-induced diabetes mellitus in rats [117]. 3.4. Neuroprotective"/>
 <result pre="been shown to alleviate inflammation induced by hyperglycemia in streptozotocin-nicotinamide-induced" exact="diabetes mellitus" post="in rats [117]. 3.4. Neuroprotective Action In comparison to"/>
 <result pre="was reported that naringenin has protective effects in experimental ischemic" exact="stroke" post="models with improvement in neurological insufficiency and brain swelling"/>
 <result pre="profile [119]. Naringenin was found to reduce the chances of" exact="atherosclerosis" post="by alleviating dyslipidemia and insulin resistance, thereby inhibiting the"/>
 <result pre="was found to reduce the chances of atherosclerosis by alleviating" exact="dyslipidemia" post="and insulin resistance, thereby inhibiting the assembly of apolipoprotein"/>
 <result pre="IBDs are known to progress to more severe forms like" exact="ulcerative colitis" post="[156] and Crohnâ€™s disease (CD). In such cases, treatment"/>
 <result pre="are known to progress to more severe forms like ulcerative" exact="colitis" post="[156] and Crohnâ€™s disease (CD). In such cases, treatment"/>
 <result pre="addition, beneficial effects of naringenin may also be accomplished through" exact="suppression" post="of pro-inflammatory markers like iNOS, reduction of inflammatory cytokines,"/>
 <result pre="SGC-7901 cell lines, naringenin exhibited induction of apoptosis along with" exact="suppression" post="of proliferation, migration, and invasion. The possible reason may"/>
 <result pre="et al. have reported that naringenin suppressed the growth of" exact="stomach cancer" post="cells in SGC-7901 cell lines [164]. 3.8. Role of"/>
 <result pre="al. have reported that naringenin suppressed the growth of stomach" exact="cancer" post="cells in SGC-7901 cell lines [164]. 3.8. Role of"/>
 <result pre="of Naringenin in Pulmonary Diseases Lung diseases such as asthma," exact="chronic obstructive pulmonary disease" post="(COPD), lung cancer, and pulmonary fibrosis are chronic airway"/>
 <result pre="Lung diseases such as asthma, chronic obstructive pulmonary disease (COPD)," exact="lung cancer," post="and pulmonary fibrosis are chronic airway inflammatory diseases (CAID)"/>
 <result pre="as asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and" exact="pulmonary fibrosis" post="are chronic airway inflammatory diseases (CAID) characterized by inflammatory"/>
 <result pre="Des.2016224341435910.2174/138161282266616053015093627238365 6.ShakeelS.RehmanM.U.TabassumN.AminU.Effect of naringenin (A naturally occurring flavanone) against pilocarpine-induced" exact="status epilepticus" post="and oxidative stress in micePharm. Mag.20171315410.4103/0973-1296.203977 7.MirI.A.TikuA.B.Chemopreventive and therapeutic"/>
 <result pre="fruitsNutr. Cancer201567274210.1080/01635581.2015.97632025514618 8.AlamM.A.SubhanN.RahmanM.M.UddinS.J.RezaS.Effect of citrus flavonoids, naringin and naringenin, on" exact="metabolic syndrome" post="and their mechanisms of actionAdv. Nutr.2014540441710.3945/an.113.00560325022990 9.ZaidunN.H.ThentZ.C.LatiffA.A.Combating oxidative stress"/>
 <result pre="of the CD95 (APOâ€&quot;1/Fas) receptor/ligand system in drugâ€&quot;induced apoptosis in" exact="leukemia" post="cellsNat. Med.1996257410.1038/nm0596-5748616718 33.DurgoK.KoncarM.KomesD.Belscak-CvitanovicA.FranekicJ.JakopovichI.JakopovichB.Cytotoxicity of blended versus single medicinal mushroom"/>
 <result pre="33.DurgoK.KoncarM.KomesD.Belscak-CvitanovicA.FranekicJ.JakopovichI.JakopovichB.Cytotoxicity of blended versus single medicinal mushroom extracts on human" exact="cancer" post="cell lines: Contribution of polyphenol and polysaccharide contentInt. J."/>
 <result pre="anti-cancer therapyInt. J. Biochem. Cell Biol.2013452821283110.1016/j.biocel.2013.10.00424128857 35.StefaniE.D.RoncoA.MendilaharsuM.Deneo-PellegriniH.Diet and risk of" exact="cancer" post="of the upper aerodigestive tractâ€&quot;II. NutrientsOral Oncol.199935222610.1016/S1368-8375(98)00061-X10211306 36.TiwariP.MishraN.D.Role of"/>
 <result pre="of Wistar ratsEnviron. Toxicol.20183342243510.1002/tox.2252829345053 43.KawaiiS.TomonoY.KataseE.OgawaK.YanoM.Antiproliferative activity of flavonoids on several" exact="cancer" post="cell linesBiosci. Biotechnol. Biochem.19996389689910.1271/bbb.63.89610380632 44.PougetC.LauthierF.SimonA.FagnereC.BaslyJ.P.DelageC.ChuliaA.J.Flavonoids: Structural requirements for antiproliferative"/>
 <result pre="linesBiosci. Biotechnol. Biochem.19996389689910.1271/bbb.63.89610380632 44.PougetC.LauthierF.SimonA.FagnereC.BaslyJ.P.DelageC.ChuliaA.J.Flavonoids: Structural requirements for antiproliferative activity on" exact="breast cancer" post="cellsBioorg. Med. Chem. Lett.2001113095309710.1016/S0960-894X(01)00617-511720850 45.ChangW.S.LeeY.J.LuF.J.ChiangH.C.Inhibitory effects of flavonoids on"/>
 <result pre="Biotechnol. Biochem.19996389689910.1271/bbb.63.89610380632 44.PougetC.LauthierF.SimonA.FagnereC.BaslyJ.P.DelageC.ChuliaA.J.Flavonoids: Structural requirements for antiproliferative activity on breast" exact="cancer" post="cellsBioorg. Med. Chem. Lett.2001113095309710.1016/S0960-894X(01)00617-511720850 45.ChangW.S.LeeY.J.LuF.J.ChiangH.C.Inhibitory effects of flavonoids on"/>
 <result pre="in male F344 ratsCarcinogenesis1997182155216110.1093/carcin/18.11.21559395216 48.ChandrikaB.B.SteephanM.KumarT.R.S.SabuA.HaridasM.Hesperetin and Naringenin sensitize HER2 positive" exact="cancer" post="cells to death by serving as HER2 Tyrosine Kinase"/>
 <result pre="C and nuclear oncogene expression as possible molecular mechanisms of" exact="cancer" post="chemoprevention by apigenin and curcuminJ. Cell. Biochem.199728394810.1002/(SICI)1097-4644(1997)28/29+&amp;lt;39::AID-JCB5&amp;gt;3.0.CO;2-X 51.WeberG.ShenF.PrajdaN.YangH.LiW.YehA.LookK.Y.Regulation of"/>
 <result pre="induces growth inhibition, cell cycle arrest and apoptosis in human" exact="hepatocellular carcinoma" post="cellsPathol. Oncol. Res.20131976377010.1007/s12253-013-9641-123661153 53.StoimenovI.HelledayT.PCNA on the crossroad of cancerBiochem."/>
 <result pre="the apoptosis-inducing activity of flavonoidsBiochem. Pharmacol.2003661139115010.1016/S0006-2952(03)00455-614505793 56.ZhaoZ.JinG.GeY.GuoZ.Naringenin inhibits migration of" exact="breast cancer" post="cells via inflammatory and apoptosis cell signaling pathwaysInflammopharmacology2019271021103610.1007/s10787-018-00556-330941613 57.WangI.K.Lin-ShiauS.Y.LinJ.K.Induction"/>
 <result pre="apoptosis-inducing activity of flavonoidsBiochem. Pharmacol.2003661139115010.1016/S0006-2952(03)00455-614505793 56.ZhaoZ.JinG.GeY.GuoZ.Naringenin inhibits migration of breast" exact="cancer" post="cells via inflammatory and apoptosis cell signaling pathwaysInflammopharmacology2019271021103610.1007/s10787-018-00556-330941613 57.WangI.K.Lin-ShiauS.Y.LinJ.K.Induction"/>
 <result pre="and ÃŸ SignallingIUBMB20045649149910.1080/15216540400010792 60.BulzomiP.BolliZ.Z.GalluzzoP.LeoneS.AcconciaF.MarinoM.Naringenin and 17Î²-estradiol coadministration prevents hormone-induced human" exact="cancer" post="cell growthIUBMB201062516010.1002/iub.279 61.MorikawaK.NonakaM.MochizukiH.HandaK.HanadaH.HirotaK.Naringenin and hesperetin induce growth arrest, apoptosis,"/>
 <result pre="permeability and prevent erythrocyte oxidative damageBiochim. Biophys. Acta2020186218344210.1016/j.bbamem.2020.18344232814117 63.CarmelietP.JainR.K.Angiogenesis in" exact="cancer" post="and other diseasesNature200040724910.1038/3502522011001068 64.FerraraN.AlitaloK.Clinical applications of angiogenic growth factors"/>
 <result pre="65.TosettiF.FerrariN.De FloraS.AlbiniA.Angiopreventionâ€™: Angiogenesis is a common and key target for" exact="cancer" post="chemopreventive agentsFASEB J.20021621410.1096/fj.01-0300rev11772931 66.AnandK.SarkarA.KumarA.AmbastaP.K.KumarP.Combinatorial antitumor effect of naringenin and"/>
 <result pre="and metastasis by inhibiting TGF-Î²-induced epithelial to mesenchymal transition in" exact="pancreatic cancer" post="cellsPLoS ONE201275095610.1371/journal.pone.0050956 68.PrabhakarP.KumarA.DobleM.Combination therapy: A new strategy to manage"/>
 <result pre="metastasis by inhibiting TGF-Î²-induced epithelial to mesenchymal transition in pancreatic" exact="cancer" post="cellsPLoS ONE201275095610.1371/journal.pone.0050956 68.PrabhakarP.KumarA.DobleM.Combination therapy: A new strategy to manage"/>
 <result pre="Î±-glucosidase activity: A promising strategy for the regulation of postprandial" exact="hyperglycemia" post="in high fat diet fed streptozotocin induced diabetic ratsChem."/>
 <result pre="syndromeEur. J. Nutr.20104910110910.1007/s00394-009-0054-619727895 73.MulvihillE.AllisterE.M.SutherlandB.G.TelfordD.E.SawyezC.G.EdwardsJ.Y.HuffM.H.Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and" exact="hyperinsulinemia" post="in LDL receptorâ€&quot;null mice with diet-induced insulin resistanceDiabetes2009582198221010.2337/db09-063419592617 74.PurushothamA.TianM.BeluryM.The"/>
 <result pre="an innate immune system response in human adipose tissue in" exact="obesity" post="and type 2 diabetesAm. J. Physiol.200729274074710.1152/ajpendo.00302.200617090751 76.HeoH.C.KimM.J.LeeJ.M.ChoiS.J.ChoH.Y.HongB.ShinD.H.Naringenin from Citrus"/>
 <result pre="potential of rosiglitazone in tibial and sural nerve transection-induced painful" exact="neuropathy" post="in ratsPharmacol. Res.20095938539210.1016/j.phrs.2009.02.00119429470 88.FreshwaterJ.D.SvenssonC.I.MalmbergA.B.CalcuttN.A.Elevated spinal cyclooxygenase and prostaglandin release"/>
 <result pre="on brain insulin signaling and cognitive functions in ICV-STZ induced" exact="dementia" post="model of ratsNeurol. Sci.20143574175110.1007/s10072-013-1594-324337945 127.SarubboF.RamisM.KienzerC.AparicioS.EstebanS.MirallesA.MorantaD.Chronic silymarin, quercetin and naringenin"/>
 <result pre="ratsJ. Neuroimmune Pharmacol.201813243810.1007/s11481-017-9759-028808887 128.RazaS.KhanM.AhmadA.AshafaqM.IslamF.WagnerA.SafhiM.Neuroprotective effect of naringenin is mediated through" exact="suppression" post="of NF-ÎºB signaling pathway in experimental strokeNeuroscience201323015717110.1016/j.neuroscience.2012.10.04123103795 129.BaiX.ZhangX.ChenL.ZhangJ.ZhangL.ZhaoX.ZhaoY.Protective effect"/>
 <result pre="oxidative stressBiol. Trace Elem. Res.201415837638310.1007/s12011-014-9948-024682942 131.KhanM.B.KhanM.M.KhanA.AhmedM.E.IshratT.TabassumR.IslamF.Naringenin ameliorates Alzheimerâ€™s disease (AD)-type" exact="neurodegeneration" post="with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in"/>
 <result pre="juice on QT variability in patients with dilated or hypertensive" exact="cardiomyopathy" post="and in healthy subjectsTransl. Res.200815126727210.1016/j.trsl.2008.03.00218433709 142.ZhangN.YangZ.YuanY.LiF.LiuY.MaZ.ZhouH.Naringenin attenuates pressure overload-induced"/>
 <result pre="Daunorubicin-induced Toxicity in H9c2 CardiomyoblastsPhytother. Res.20092313613910.1002/ptr.256618803248 145.MulvihillE.E.AssiniS.B.G.DiMattiaA.S.KhamiM.KoppesJ.B.HuffM.W.Naringenin decreases progression of" exact="atherosclerosis" post="by improving dyslipidemia in highfatfed lowdensity lipoprotein receptornull miceArterioscler."/>
 <result pre="H9c2 CardiomyoblastsPhytother. Res.20092313613910.1002/ptr.256618803248 145.MulvihillE.E.AssiniS.B.G.DiMattiaA.S.KhamiM.KoppesJ.B.HuffM.W.Naringenin decreases progression of atherosclerosis by improving" exact="dyslipidemia" post="in highfatfed lowdensity lipoprotein receptornull miceArterioscler. Thromb. Vasc. Biol.20103074274810.1161/ATVBAHA.109.20109520110573"/>
 <result pre="155.HossainM.M.BanikN.L.RayS.K.Survivin knockdown increased anti-cancer effects of (âˆ’)-epigallocatechin-3-gallate in human malignant" exact="neuroblastoma" post="SK-N-BE2 and SH-SY5Y cellsExp. Cell Res.20123181597161010.1016/j.yexcr.2012.03.03322507272 156.Orrego-LagarÃ³nN.MartÃ­nez-HuÃ©lamoM.VallverdÃº-QueraltA.Lamuela-RaventosR.M.Escribano-FerrerE.High gastrointestinal permeability"/>
 <result pre="cellsMol. Cell. Biochem.2011351294010.1007/s11010-010-0708-y21229383 158.Al-RejaieS.S.AbuohashishH.M.Al-EnaziM.M.Al-AssafA.H.ParmarM.Y.AhmedM.M.Protective effect of naringenin on acetic acid-induced" exact="ulcerative colitis" post="in ratsWorld J. Gastroenterol.2013195633564410.3748/wjg.v19.i34.563324039355 159.DouW.ZhangJ.SunA.ZhangE.DingL.MukherjeeS.ManiS.Protective effect of naringenin against"/>
 <result pre="Cell. Biochem.2011351294010.1007/s11010-010-0708-y21229383 158.Al-RejaieS.S.AbuohashishH.M.Al-EnaziM.M.Al-AssafA.H.ParmarM.Y.AhmedM.M.Protective effect of naringenin on acetic acid-induced ulcerative" exact="colitis" post="in ratsWorld J. Gastroenterol.2013195633564410.3748/wjg.v19.i34.563324039355 159.DouW.ZhangJ.SunA.ZhangE.DingL.MukherjeeS.ManiS.Protective effect of naringenin against"/>
 <result pre="in ratsWorld J. Gastroenterol.2013195633564410.3748/wjg.v19.i34.563324039355 159.DouW.ZhangJ.SunA.ZhangE.DingL.MukherjeeS.ManiS.Protective effect of naringenin against experimental" exact="colitis" post="via suppression of Toll-like receptor 4/NF-ÎºB signallingBr. J. Nutr.201311059960810.1017/S000711451200559423506745"/>
 <result pre="J. Gastroenterol.2013195633564410.3748/wjg.v19.i34.563324039355 159.DouW.ZhangJ.SunA.ZhangE.DingL.MukherjeeS.ManiS.Protective effect of naringenin against experimental colitis via" exact="suppression" post="of Toll-like receptor 4/NF-ÎºB signallingBr. J. Nutr.201311059960810.1017/S000711451200559423506745 160.ManabeN.WongB.S.CamilleriM.New-generation 5-HT4"/>
 <result pre="migration, and invasion as well as induces apoptosis of gastric" exact="cancer" post="SGC7901 cell line by downregulation of AKT pathwayTumor Biol.201637113651137410.1007/s13277-016-5013-226960693"/>
 <result pre="anticancer effect of ABT-737 in combination with naringenin on gastric" exact="cancer" post="cellsExp. Ther. Med.20161166967310.3892/etm.2015.291226893664 165.ChinL.H.HonC.M.ChellappanD.K.ChellianJ.MadheswaranT.ZeeshanF.AwasthiR.AljabaliA.A.TambuwalaM.M.DurejaH.et al.Molecular mechanisms of action of"/>
 <result pre="of naringenin in the regulation of several pathways involved in" exact="metabolic syndrome." post=""/>
</results>
